Multidrug-Resistant Pseudomonas aeruginosa Triggers Differential Inflammatory Response in Patients With

Poonam Naik1,2, Sukhvinder Singh3, Dhanwini Rudraprasad1

  • 1Jhaveri Microbiology Centre, Brien Holden Eye Research Centre, L V Prasad Eye Institute, Hyderabad, Telangana, India.

Abstract

Insights

Multidrug-resistant Pseudomonas aeruginosa (MDR-PA) endophthalmitis triggers a distinct immune response, with elevated cytokines linked to disease severity. This highlights potential biomarkers for early diagnosis and intervention to prevent vision loss.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Immunology

Background:

  • Multidrug-resistant Pseudomonas aeruginosa (MDR-PA) infections cause poor outcomes in endophthalmitis.
  • The host immune response to MDR-PA in endophthalmitis is not well understood.

Purpose of the Study:

  • To investigate the association between MDR-PA infection and cytokine expression profiles in endophthalmitis patients.
  • To correlate immune mediator levels with clinical severity and immune pathway activation.

Main Methods:

  • Vitreous samples from MDR-PA, antibiotic-susceptible P. aeruginosa (S-PA), and non-infectious control groups were analyzed.
  • Multiplex immunoassay was used to measure cytokine expression (IL-6, IL-10, IL-1α, IL-1β, IFN-γ, TNF-α, IL-8, GM-CSF).
  • Immune pathway phosphorylation levels were assessed.

Main Results:

  • MDR-PA endophthalmitis showed significantly increased expression of IL-6, IL-8, IL-10, IL-1β, and TNF-α compared to S-PA.
  • Elevated inflammatory mediators correlated with increased disease severity.
  • Increased inflammatory mediators were positively correlated with the activation of Akt, STAT3, JNK, p70 S6 kinase, and NF-κB signaling pathways.

Conclusions:

  • MDR-PA endophthalmitis elicits a differential host immune response involving specific cytokine profiles and signaling pathway activation.
  • Cytokine levels (IL-6, IL-8, IL-10, IL-1β, TNF-α) may serve as diagnostic biomarkers for MDR endophthalmitis.
  • Early identification and immune modulation are crucial to prevent retinal damage and vision loss.